unexpectedli
larg
outbreak
middl
east
respiratori
syndrom
south
korea
initi
infect
travel
amplifi
sever
superspread
event
previous
report
emerg
spread
mutant
middl
east
respiratori
syndrom
coronaviru
bear
spike
mutat
reduc
affin
human
receptor
outbreak
assess
potenti
associ
spike
mutat
superspread
event
collect
viru
genet
inform
report
outbreak
system
analyz
relationship
spike
sequenc
epidemiolog
found
sequenti
emerg
spike
mutat
superspread
vivo
virul
mutant
virus
seem
declin
human
patient
assess
fever
durat
affect
person
addit
neutral
activ
mutant
virus
serum
sampl
mice
immun
wildtyp
spike
antigen
gradual
reduc
suggest
emerg
wide
spread
neutral
escap
outbreak
merscov
newli
emerg
zoonot
pathogen
caus
acut
fatal
respiratori
diseas
acut
pneumonia
patient
saudi
arabia
sinc
associ
confirm
case
death
rate
countri
march
http
wwwwhointemergenciesmerscov
although
primari
transmiss
merscov
human
link
contact
dromedari
camel
outbreak
case
associ
humantohuman
transmiss
especi
healthcar
set
mayjuli
unexpectedli
larg
outbreak
mer
swept
south
korea
result
confirm
case
death
death
rate
outbreak
initi
infect
travel
middl
east
region
amplifi
sever
superspread
event
defin
humantohuman
transmiss
healthcar
set
three
superspread
epidemiolog
link
human
transmiss
infect
subject
respect
even
though
nosocomi
superspread
might
facilit
delay
diagnosi
poor
infect
control
healthcar
facil
contribut
biolog
factor
includ
host
respons
virolog
chang
poorli
character
addit
superspread
event
continu
sporad
aris
lead
unexpectedli
larg
outbreak
mer
therefor
hostpathogen
interact
drive
viru
evolut
human
adapt
potenti
associ
rare
superspread
event
host
chang
enzoonot
viru
need
investig
previou
studi
report
emerg
spread
mutant
merscov
bear
spike
mutat
receptor
bind
domain
rbd
reduc
affin
human
receptor
south
korea
outbreak
unexpect
find
suggest
merscov
adapt
humantohuman
spread
might
driven
host
immunolog
pressur
neutral
antibodi
result
impair
viru
fit
virul
rather
posit
select
better
affin
recent
report
also
show
chang
reduc
spike
protein
bind
diminish
viru
entri
assess
potenti
contribut
new
emerg
mutat
superspread
event
collect
viru
genet
inform
report
south
korea
outbreak
system
analyz
variat
especi
spike
sequenc
relationship
individu
diseas
sever
epidemiolog
also
attempt
confirm
whether
spike
mutat
affect
viru
dynam
vitro
infect
model
viru
escap
neutral
antibodi
respons
use
serum
sampl
mice
immun
wildtyp
spike
antigen
mer
patient
south
korea
infect
wildtyp
viru
system
overview
clinic
virolog
data
obtain
transient
larg
outbreak
driven
unexpect
superspread
event
among
human
might
provid
novel
insight
understand
evolutionari
pathway
emerg
coronaviru
animaltohuman
transmiss
collect
genet
inform
spike
gene
merscov
analyz
patient
specimen
nation
center
biotechnolog
inform
http
wwwncbi
nlmnihgov
previou
analysi
park
et
al
januari
total
spike
gene
sequenc
patient
south
korea
avail
analysi
appendix
tabl
http
wwwnccdcgoveid
baselin
characterist
patient
summar
tabl
appendix
tabl
clinic
data
serum
sampl
obtain
mer
patient
use
studi
experiment
method
describ
fulli
appendix
studi
conduct
accord
ethic
standard
laid
declar
helsinki
subsequ
revis
anim
experi
approv
seoul
nation
univers
institut
anim
care
use
committe
permit
perform
strict
accord
recommend
south
korea
nation
guidelin
care
use
laboratori
anim
collect
analyz
genet
inform
spike
gene
report
south
korea
outbreak
inform
spike
mutat
patient
sampl
date
summar
appendix
tabl
timelin
detect
spike
mutat
depict
figur
focus
mutat
rbd
region
novel
mutat
substanti
reduc
merscov
affin
human
receptor
observ
multipl
patient
outbreak
addit
nonsynonym
spike
mutat
consist
associ
spike
mutat
appendix
tabl
wildtyp
merscov
detect
index
patient
may
howev
mutat
observ
day
later
may
suggest
mutat
emerg
within
day
symptom
onset
potenti
chang
spike
gene
consist
fact
earli
contactor
also
carri
wildtyp
viru
subsequ
patient
includ
superspread
infect
mutant
virus
moreov
second
mutat
first
detect
respiratori
sampl
collect
june
includ
mix
spike
sequenc
wildtyp
rare
doubl
mutat
even
though
patient
infect
carri
merscov
mutat
second
mutant
transient
consist
observ
tertiari
quaternari
case
result
indic
initi
harbor
mix
wildtyp
mutant
virus
gener
mutat
mutant
viru
domin
exposur
period
addit
patient
spread
mutant
simultan
subsequ
humantohuman
transmiss
mutant
detect
patient
group
infect
infect
indic
probabl
origin
mutat
mutant
initi
domin
patient
wildtyp
merscov
later
overtook
major
popul
suggest
fluctuat
wildtyp
mutant
virus
host
whether
spike
mutat
merscov
associ
diseas
morbid
yet
determin
review
clinic
data
patient
viru
spike
sequenc
inform
avail
classifi
group
basi
diseas
sever
death
rate
mer
outbreak
tabl
appendix
tabl
group
includ
person
asymptomat
fever
without
pneumonia
group
ii
includ
patient
mild
pneumonia
without
hypoxemia
twelv
person
recov
prolong
sever
pneumonia
classifi
group
iii
group
iii
subject
experienc
hypoxemia
treat
oxygen
hospit
eleven
patient
die
acut
respiratori
distress
syndrom
classifi
group
iv
baselin
characterist
patient
includ
exposur
period
date
symptom
onset
fever
durat
summar
figur
appendix
tabl
initi
assess
potenti
associ
spike
mutat
diseas
sever
tabl
could
observ
statist
signific
associ
mer
sever
spike
mutat
mix
spike
genotyp
infect
howev
averag
day
fever
durat
mer
patient
gener
longer
case
associ
wildtyp
viru
mean
sd
day
mix
infect
includ
wildtyp
mean
sd
day
compar
fever
patient
infect
mean
sd
day
mean
sd
mutant
figur
panel
even
though
differ
fever
durat
patient
group
associ
wildtyp
viru
includ
mix
infect
day
infect
either
mutant
virus
mean
sd
day
statist
margin
p
figur
panel
b
potenti
limit
data
reduct
fever
durat
patient
associ
primari
secondari
mutat
seem
consist
diseas
sever
casefat
rate
mer
associ
viral
load
next
examin
whether
mutant
virus
reduc
affin
human
receptor
also
reduc
celltocel
spread
viru
growth
perform
plaqueform
assay
vitro
compar
viral
plaqu
wildtyp
merscov
averag
size
viral
plaqu
form
mutant
merscov
mean
sd
mm
significantli
smaller
wildtyp
viru
mean
sd
mm
vero
cell
figur
panel
c
consist
observ
human
embryon
kidney
cell
line
cell
overexpress
human
figur
panel
averag
size
plaqu
induc
mutant
mean
sd
mm
also
smaller
wildtyp
merscov
mean
sd
mm
cell
result
clearli
indic
spike
mutat
gener
south
korea
outbreak
reduc
transmiss
reduc
growth
rate
vitro
infect
model
examin
whether
spike
mutat
affect
sensit
neutral
activ
antibodi
wildtyp
spike
investig
whether
antibodi
gener
mice
immun
wildtyp
spike
antigen
abl
neutral
spike
mutant
virus
effici
wildtyp
viru
perform
pseudoparticl
neutral
test
assay
wildtyp
mutant
spikepseudotyp
lentivirus
compar
neutral
efficaci
averag
titer
serum
sampl
immun
mice
show
gradual
decreas
neutral
mean
sd
mutant
virus
wildtyp
viru
mean
sd
figur
panel
demonstr
mutant
virus
neutral
escap
final
measur
neutral
antibodi
titer
use
plaqu
reduct
neutral
test
prnt
merscov
bear
wildtyp
mutant
serum
sampl
recov
patient
carri
wildtyp
merscov
neutral
efficaci
prnt
titer
serum
sampl
wildtyp
merscov
consist
higher
mutant
merscov
figur
panel
b
averag
prnt
titer
serum
sampl
wildtyp
mean
sd
higher
mutant
merscov
mean
sd
indic
mutant
merscov
escap
better
neutral
antibodi
gener
infect
wildtyp
viru
prnt
titer
serum
sampl
sever
diseas
higher
mild
symptom
even
though
multipl
environment
behavior
factor
might
associ
zoonot
coronaviru
outbreak
human
popul
advent
superspread
caus
larg
number
new
infect
earli
stage
outbreak
might
play
critic
amplifi
role
superspread
person
well
document
previou
sever
acut
respiratori
syndrom
sar
epidem
recent
ongo
mer
outbreak
although
underli
biolog
caus
determin
superspread
still
poorli
understood
superspread
event
zoonot
coronavirus
might
relat
higher
level
viru
shed
prolong
period
uncontrol
exposur
suscept
contact
earli
outbreak
need
infect
control
appreci
studi
system
assess
merscov
genet
chang
mer
outbreak
korea
highlight
potenti
biolog
factor
associ
shortterm
evolutionari
pathway
zoonot
coronaviru
adapt
human
popul
context
superspread
event
microevolut
toward
reduc
host
affin
merscov
might
associ
host
antibodi
respons
studi
show
antibodi
gener
immun
mice
wildtyp
spike
antigen
human
patient
recov
wildtyp
merscov
infect
gener
less
effici
neutral
mutant
viru
bear
spike
mutat
wildtyp
viru
figur
addit
vitro
viru
growth
mutant
merscov
celltocel
spread
significantli
reduc
compar
wildtyp
viru
figur
panel
c
given
amino
acid
differ
spike
rbd
nonsynonym
nucleotid
chang
throughout
whole
viru
genom
genbank
access
wildtyp
mutant
wildtyp
mutant
isol
korea
use
studi
differ
plaqu
size
primarili
attribut
spike
mutat
appendix
tabl
recent
studi
demonstr
chang
increas
resist
spike
proteindriven
entri
neutral
monoclon
antibodi
serum
mer
patient
studi
also
confirm
chang
reduc
spike
protein
bind
show
reduct
translat
diminish
viru
entri
express
target
cell
low
neither
mutat
modul
spike
protein
bind
sialic
acid
spike
protein
activ
host
cell
proteas
inhibit
spike
proteindriven
entri
interferoninduc
transmembran
protein
studi
howev
consist
observ
averag
size
viral
plaqu
form
mutant
merscov
bear
mutat
significantli
reduc
type
permiss
cell
vero
cell
express
high
level
compar
wildtyp
merscov
figur
previou
studi
employ
pseudotyp
vesicular
stomat
viru
system
bear
wildtyp
mutant
merscov
spike
protein
current
result
use
merscov
isol
human
patient
might
reflect
intrins
characterist
spike
protein
context
natur
form
merscov
studi
need
character
effect
spike
mutat
viru
growth
spread
vitro
vivo
infect
system
emerg
spike
mutat
affect
affin
host
receptor
might
critic
caus
superspread
event
similar
observ
made
regard
sar
epidem
howev
mutat
gener
enhanc
affin
spike
human
receptor
detect
begin
humantohuman
transmiss
sar
epidem
mer
outbreak
south
korea
associ
viru
mutat
chang
affin
human
receptor
oppos
way
sarscov
acquir
mutat
replic
effici
becom
pathogen
wherea
merscov
mutant
less
affin
receptor
human
cell
potenti
less
pathogen
emerg
superspread
outbreak
south
korea
recent
studi
report
merscov
sarscov
spike
trimer
inher
flexibl
rbd
structur
state
buri
flat
expos
stand
posit
observ
cryoelectron
microscop
analysi
studi
propos
molecul
might
crosslink
merscov
spike
trimer
bind
stand
rbd
trimer
wherea
monomer
receptor
bind
sarscov
spike
trimer
receptor
spike
trimer
enabl
merscov
higher
avid
receptor
bind
sarscov
inher
differ
avid
cellular
receptor
spike
trimer
might
partial
explain
anim
coronavirus
evolv
oppos
direct
term
receptor
affin
switch
host
human
popul
spike
mutat
higher
affin
might
way
ensur
success
humantohuman
transmiss
sarscov
intrins
lower
avid
wherea
higher
spike
avid
merscov
might
afford
viru
spike
mutat
lower
affin
human
receptor
increas
antibodi
escap
therefor
vaccin
immunogen
design
broadli
rais
neutral
antibodi
would
prefer
target
conserv
surfac
expos
stem
region
rather
rbd
recent
studi
show
singl
mutat
make
influenza
viru
complet
resist
narrow
strainspecif
antibodi
broad
antibodi
target
residu
hemagglutinin
rbd
wherea
broad
antibodi
hemagglutinin
stalk
resist
viru
escap
singl
mutat
microevolut
spike
gene
merscov
toward
reduc
human
affin
enhanc
escap
neutral
antibodi
singl
patient
might
increas
probabl
spread
event
extend
viru
replic
period
host
superspread
south
korea
belong
group
iii
sever
prolong
viral
pneumonia
group
iii
patient
produc
significantli
higher
number
virus
respiratori
secret
longer
period
patient
milder
case
superspread
south
korea
suspect
produc
merscov
high
copi
number
copiesml
respiratori
secret
earli
phase
mer
symptom
develop
exposur
suscept
contact
day
also
posit
viru
respiratori
secret
prolong
period
day
respect
symptom
onset
even
isol
addit
new
spike
mutant
emerg
index
patient
combin
infect
patient
within
week
symptom
onset
harbor
mix
infect
wildtyp
spike
mutant
virus
consequ
spread
mix
virus
earli
phase
outbreak
figur
mix
infect
wildtyp
spike
mutant
virus
confirm
major
tertiari
casepati
infect
target
deep
sequenc
intrapati
heterogen
merscov
highest
superspread
specimen
although
frequenc
vari
greatli
among
specimen
analyz
use
target
deep
sequenc
combin
frequenc
singl
mutant
consist
high
averag
wherea
frequenc
wildtyp
low
averag
support
hypothesi
select
pressur
exert
host
neutral
antibodi
respons
play
critic
role
shape
genet
variant
fluctuat
wildtyp
popul
higher
affin
host
mutant
virus
escap
neutral
antibodi
singl
person
might
facilit
sustain
viru
replic
higher
load
wildtyp
viru
domin
sever
tertiari
patient
eg
later
stage
infect
although
mutant
viru
major
popul
earlier
stage
figur
hypotens
chronic
respiratori
diseas
pancreat
lymphoma
respiratori
ill
infect
die
day
symptom
onset
die
lymphoma
day
symptom
onset
case
wildtyp
mutant
virus
detect
initi
suggest
mix
infect
patient
might
suffer
immunosuppress
upon
viru
infect
either
initi
high
viral
load
case
observ
fatal
case
previou
cancer
treatment
case
fail
adapt
immun
patient
might
provid
specif
environ
allow
wildtyp
viru
higher
affin
host
resurg
among
mix
popul
later
stage
infect
inde
serial
sampl
show
substanti
decreas
normal
leukocyt
count
simultan
increas
frequenc
wildtyp
allel
result
suggest
select
pressur
exert
host
immun
respons
might
favor
variant
reduc
affin
host
receptor
wildtyp
viru
high
affin
domin
immun
pressur
reduc
taken
togeth
emerg
antibodi
escap
mutant
mount
immunolog
pressur
host
might
ensur
sustain
viru
replic
higher
viru
shed
respiratori
secret
longer
period
delay
antigenspecif
immun
therebi
increas
probabl
patient
becom
superspread
nevertheless
evolutionari
pathway
coronavirus
humantohuman
spread
might
result
serial
decreas
host
affin
pathogen
well
milder
respiratori
symptom
transmiss
human
popul
properli
restrict
initi
outbreak
stage
